Etiology of Bronchopulmonary Dysplasia: Before Birth

被引:1
作者
Zeitlin, Pamela L. [1 ]
Nogee, Lawrence M. [2 ]
机构
[1] Johns Hopkins Med Inst, Eudowood Div Pediat Resp Sci, Baltimore, MD 21287 USA
[2] Johns Hopkins Med Inst, Div Neonatol, Baltimore, MD 21287 USA
关键词
EXTREMELY PRETERM INFANTS; SURFACTANT PROTEIN-A; INSTITUTES-OF-HEALTH; CHRONIC LUNG-DISEASE; PREMATURE-INFANTS; CYSTIC-FIBROSIS; IN-UTERO; INJURY; GENE; INFLAMMATION;
D O I
10.1089/ped.2011.0074
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Bronchopulmonary dysplasia affects thousands of infants annually with high attendant morbidity, mortality, and healthcare costs. Respiratory outcomes for preterm infants may be widely disparate even within the same medical center for infants of similar gestational ages. Given the high estimates for the heritability for bronchopulmonary dysplasia as measured at 36 weeks of postmenstrual age, the course of disease for a particular infant is likely heavily influenced by factors that operate prenatally or in the early postnatal period. In this review we discuss the etiologies of lung disease in the premature infant, including in utero, genetic, and epigenetic factors that may influence pulmonary outcomes.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 48 条
  • [1] Epigenetic regulation of airway inflammation
    Adcock, Ian M.
    Tsaprouni, Loukia
    Bhavsar, Pankaj
    Ito, Kazuhiro
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2007, 19 (06) : 694 - 700
  • [2] Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia?
    Antonucci, R
    Contu, P
    Porcella, A
    Atzeni, C
    Chiappe, S
    [J]. JOURNAL OF PERINATAL MEDICINE, 2004, 32 (03) : 272 - 277
  • [3] Use of Azithromycin for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants: A Randomized, Double-Blind, Placebo Controlled Trial
    Ballard, Hubert O.
    Shook, Lori A.
    Bernard, Philip
    Anstead, Michael I.
    Kuhn, Robert
    Whitehead, Vicki
    Grider, Deb
    Crawford, Timothy N.
    Hayes, Don, Jr.
    [J]. PEDIATRIC PULMONOLOGY, 2011, 46 (02) : 111 - 118
  • [4] Surfactant function and composition in premature infants treated with inhaled nitric oxide
    Ballard, Philip L.
    Merrill, Jeffrey D.
    Truog, William E.
    Godinez, Rodolfo I.
    Godinez, Marye H.
    McDevitt, Theresa M.
    Ning, Yue
    Golombek, Sergio G.
    Parton, Lance A.
    Luan, Xianqun
    Cnaan, Avital
    Ballard, Roberta A.
    [J]. PEDIATRICS, 2007, 120 (02) : 346 - 353
  • [5] Bronchopulmonary dysplasia: Definitions and long-term respiratory outcome
    Baraldi, Eugenio
    Carraro, Silvia
    Filippone, Marco
    [J]. EARLY HUMAN DEVELOPMENT, 2009, 85 (10) : S1 - S3
  • [6] Barnes Peter J, 2009, Ther Adv Respir Dis, V3, P235, DOI 10.1177/1753465809348648
  • [7] The genetics of bronchopulmonary dysplasia
    Bhandari, Vineet
    Gruen, Jeffrey R.
    [J]. SEMINARS IN PERINATOLOGY, 2006, 30 (04) : 185 - 191
  • [8] Familial and genetic susceptibility to major neonatal morbidities in preterm twins
    Bhandari, Vineet
    Bizzarro, Matthew J.
    Shetty, Anupama
    Zhong, Xiaoyun
    Page, Grier P.
    Zhang, Heping
    Ment, Laura R.
    Gruen, Jeffrey R.
    [J]. PEDIATRICS, 2006, 117 (06) : 1901 - 1906
  • [9] Bowman RV, 2009, EXPERT OPIN THER TAR, V13, P625, DOI [10.1517/14728220902926119, 10.1517/14728220902926119 ]
  • [10] Repression of IP-10 by Interactions between Histone Deacetylation and Hypermethylation in Idiopathic Pulmonary Fibrosis
    Coward, William R.
    Watts, Keira
    Feghali-Bostwick, Carol A.
    Jenkins, Gisli
    Pang, Linhua
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2010, 30 (12) : 2874 - 2886